Taser maker Axon sees AI-related sales take off and its drone business gain momentum. Axon stock is near a buy point.

There is something deeply problematic about giving an unelected official like Elon Musk too much power with no checks and ...

The global research agenda includes 33 research priorities for bacterial and fungal infections and 7 for drug-resistant ...